Beactica Therapeutics AB
556708-2853ActivePrecision medicine company developing novel therapeutics via targeted protein degradation.
Biotechnology Companybeactica.com
Översikt
- 5–9
- Anställda
- 5–10milj SEK
- Omsättning
- 2006
- Grundat
Nyckelbeslutsfattare
Per Källblad
Chief Executive Officer
Beskrivning
Beactica Therapeutics is a precision medicine company focused on developing novel small molecule therapeutics for life-threatening diseases with significant unmet clinical needs. The company leverages its proprietary Eclipsor™ platform, which synergizes allosteric modulation and Targeted Protein Deg...
Taggar
B2BPharmaceuticals